Press
3-Year anniversary of DEA’s policy change and no action
DEA Registrant Biopharmaceutical Research Company Still Awaiting Authorization to Cultivate Cannabis for Research. Read more →
Statement on senator Durbin’s bill
Biopharmaceutical Research Company (BRC) Applauds Continued Congressional Efforts to Expand Cannabis Research. Read more →
Statement on Rep. Harris and Blumenauer bill
George Hodgin, CEO of Biopharmaceutical Research Company, praises bill to reduce barriers to medicinal cannabis research. Read more →